Deerfield Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42M | Sell |
4,692,000
-497,665
| -10% | -$4.46M | 0.76% | 32 |
|
|
2025
Q1 | $38.9M | Sell |
5,189,665
-2,954,777
| -36% | -$22.2M | 0.77% | 30 |
|
|
2024
Q4 | $61.2M | Buy |
8,144,442
+8,638
| +0.1% | +$65K | 1.16% | 25 |
|
|
2024
Q3 | $61.8M | Hold |
8,135,804
| – | – | 0.92% | 24 |
|
|
2024
Q2 | $50.3M | Buy |
8,135,804
+3,140,804
| +63% | +$19.4M | 0.84% | 30 |
|
|
2024
Q1 | $25.4M | Buy |
4,995,000
+455,475
| +10% | +$2.31M | 0.44% | 43 |
|
|
2023
Q4 | $27.2M | Buy |
4,539,525
+1,253,525
| +38% | +$7.51M | 0.5% | 38 |
|
|
2023
Q3 | $23.3M | Buy |
3,286,000
+1,964,000
| +149% | +$13.9M | 0.51% | 40 |
|
|
2023
Q2 | $9.31M | Sell |
1,322,000
-1,443,000
| -52% | -$10.2M | 0.2% | 73 |
|
|
2023
Q1 | $23.1M | Buy |
+2,765,000
| New | +$23.1M | 0.51% | 50 |
|
|
2022
Q2 | – | Sell |
-1,012,000
| Closed | -$16.5M | – | 126 |
|
|
2022
Q1 | $16.5M | Sell |
1,012,000
-674,140
| -40% | -$11M | 0.37% | 56 |
|
|
2021
Q4 | $23.4M | Buy |
1,686,140
+1,451,497
| +619% | +$20.1M | 0.49% | 48 |
|
|
2021
Q3 | $3.37M | Sell |
234,643
-2,600,357
| -92% | -$37.4M | 0.07% | 114 |
|
|
2021
Q2 | $44.8M | Buy |
2,835,000
+229,620
| +9% | +$3.63M | 0.8% | 41 |
|
|
2021
Q1 | $26.5M | Sell |
2,605,380
-3,230,430
| -55% | -$32.9M | 0.56% | 61 |
|
|
2020
Q4 | $43.5M | Buy |
5,835,810
+1,379,291
| +31% | +$10.3M | 0.86% | 35 |
|
|
2020
Q3 | $15.3M | Hold |
4,456,519
| – | – | 0.37% | 69 |
|
|
2020
Q2 | $21.2M | Sell |
4,456,519
-196,407
| -4% | -$936K | 0.62% | 54 |
|
|
2020
Q1 | $9.31M | Sell |
4,652,926
-1,722,217
| -27% | -$3.44M | 0.3% | 70 |
|
|
2019
Q4 | $22M | Buy |
6,375,143
+3,600,500
| +130% | +$12.4M | 0.7% | 46 |
|
|
2019
Q3 | $7.95M | Sell |
2,774,643
-3,518,337
| -56% | -$10.1M | 0.32% | 63 |
|
|
2019
Q2 | $23.9M | Sell |
6,292,980
-244,586
| -4% | -$927K | 0.86% | 43 |
|
|
2019
Q1 | $53.2M | Sell |
6,537,566
-373,223
| -5% | -$3.04M | 2.04% | 14 |
|
|
2018
Q4 | $55.8M | Hold |
6,910,789
| – | – | 2.23% | 11 |
|
|
2018
Q3 | $52.7M | Buy |
6,910,789
+847,293
| +14% | +$6.46M | 1.89% | 15 |
|
|
2018
Q2 | $34.7M | Sell |
6,063,496
-1,302,964
| -18% | -$7.47M | 1.22% | 28 |
|
|
2018
Q1 | $35.1M | Buy |
7,366,460
+153,067
| +2% | +$730K | 1.22% | 22 |
|
|
2017
Q4 | $35.4M | Buy |
7,213,393
+2,237,942
| +45% | +$11M | 1.39% | 26 |
|
|
2017
Q3 | $26.1M | Buy |
4,975,451
+1,476,249
| +42% | +$7.74M | 1.17% | 31 |
|
|
2017
Q2 | $19.5M | Buy |
3,499,202
+413,966
| +13% | +$2.3M | 1.04% | 30 |
|
|
2017
Q1 | $25.9M | Sell |
3,085,236
-152,498
| -5% | -$1.28M | 1% | 37 |
|
|
2016
Q4 | $20.5M | Sell |
3,237,734
-1,164,112
| -26% | -$7.37M | 0.84% | 38 |
|
|
2016
Q3 | $19.4M | Buy |
+4,401,846
| New | +$19.4M | 0.9% | 34 |
|
|
2014
Q2 | – | Sell |
-907,920
| Closed | -$9.61M | – | 120 |
|
|
2014
Q1 | $9.61M | Buy |
907,920
+39,350
| +5% | +$416K | 0.39% | 59 |
|
|
2013
Q4 | $6.6M | Sell |
868,570
-763,790
| -47% | -$5.8M | 0.34% | 63 |
|
|
2013
Q3 | $11.9M | Buy |
+1,632,360
| New | +$11.9M | 0.55% | 56 |
|